Document is current
Any future updates will be listed below
-
Authors
Kim, Mijin https://orcid.org/0000-0002-7781-9466
Panagiotakopoulou, Magdalini https://orcid.org/0000-0001-6293-4579
Chen, Chen https://orcid.org/0000-0002-4803-0183
Ruiz, Stephen B. https://orcid.org/0000-0002-1634-9798
Ganesh, Karuna https://orcid.org/0000-0002-4948-1082
Tammela, Tuomas https://orcid.org/0000-0003-3675-6961
Heller, Daniel A. https://orcid.org/0000-0002-6866-0000
- License Information
-
More Information
Article History
Accepted: 25 May 2023
First Online: 23 June 2023
Competing interests
: D.A.H. is a co-founder and officer with equity interest in Lime Therapeutics, Inc. and co-founder with equity interest in Selectin Therapeutics Inc. and Resident Diagnostics, Inc. and a member of the scientific advisory board of Concarlo Therapeutics, Inc., Nanorobotics Inc. and Mediphage Bioceuticals, Inc. T.T. has research support from ONO Pharma USA, Inc. (unrelated to this work) and is a member of the scientific advisory board of Lime Therapeutics, Inc. with equity interest. M.K., M.P., C.C., S.B.R. and K.G. declare no competing interests.
